Unknown

Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids

Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks

To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment

A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors

A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day

Promote Health With Digital Tools Among Adults With Type 2 Diabetes/Prediabetes and/or Hypertension

Clinical Effectiveness of Biologic Agents as an Adjunct to Non-surgical Periodontal Therapy of Intrabony Defects

Clinical Observation of Renal Function Reactivation Following a GRAS-Based Protocol in Patients With Chronic Kidney Disease and Long-Term Renal Arrest.

A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4)

Essential Oils for Urinary Symptoms in Multiple Sclerosis Patients

A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema

Combined Physical Therapy and Hold-Relax Technique for Adolescent Osgood-Schlatter Knee Pain

Effects of Dynamic Neuromuscular Stabilization (DNS) and Gyrotonic Training on Shoulder Function in Overhead Athletes

Confirm Rx Insertable Cardiac Monitor SMART Registry

Acute Metabolic Outcomes in Diabetic Patients Hospitalized for COVID-19 (DMD-COV)

Predictors of Disease Severity in COVID-19 Patients

Metabolic Regeneration Registry for Periodontal Health (20-Patient Cohort).

Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease